Back to search
New Onset Diabetes After Transplantation
Clinical trial pipeline · Data from ClinicalTrials.gov
See which New Onset Diabetes After Transplantation trials may be worth asking aboutClinical trial pipeline · Data from ClinicalTrials.gov
See which New Onset Diabetes After Transplantation trials may be worth asking aboutNorth America
Europe
Asia-Pacific
Rest of World
Trials may have sites in multiple countries. Filtering shows any trial with at least one site in the selected country.
The goal of this observational study is to establish risk factors for post-transplant in adult individuals with cirrhosis without diabetes undergoing liver tran…
Chronic Kidney disease (CKD) is a major global health burden and represents one of the most common non-communicable diseases. In Europe, CKD affects over 50 mil…
While the incidence of acute rejection and early graft loss have improved dramatically with the advent of newer immunosuppressant medications, improvements in l…
New onset diabetes after renal transplantation (NODAT) is a common and severe complication negatively influencing graft and patient survival. Cyclosporine (CsA)…